Alnylam Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (13 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 19,429 | 0.2% | 48,859 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 54,208 | 0.5% | 118,878 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 33,588 | 0.3% | 103,003 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 27,655 | 0.3% | 102,420 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 24,641 | 0.2% | 104,718 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 30,592 | 0.3% | 111,231 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 40,931 | 0.4% | 168,442 | 6/30/2024 |
| 2021 Q2 | 8/9/2021 | 7,768 | 0.1% | 45,822 | 6/30/2021 |
| 2020 Q4 | 1/19/2021 | 617 | 0.0% | 4,746 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 691 | 0.0% | 4,746 | 9/30/2020 |
| 2020 Q2 | 7/17/2020 | 718 | 0.0% | 4,850 | 6/30/2020 |
| 2020 Q1 | 4/16/2020 | 4,249 | 0.0% | 39,037 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 5,929 | 0.0% | 51,484 | 12/31/2019 |